Can magnesium sulfate prophylaxis reduce colistin nephrotoxicity?

Area of Science:

• Nephrology
• Pharmacology
• Toxicology

Background:

• Colistin is a potent antibiotic used for multidrug-resistant Gram-negative infections.
• Colistin administration is associated with significant nephrotoxicity, posing a clinical challenge.
• Magnesium sulfate is explored for its potential protective effects against drug-induced kidney damage.

Purpose of the Study:

• To evaluate the protective role of magnesium sulfate against colistin-induced nephrotoxicity in a rat model.
• To assess the impact of magnesium sulfate on biochemical and histopathological markers of kidney injury.

Main Methods:

• Wistar Albino rats were divided into control, colistin, magnesium sulfate, and combined magnesium sulfate-colistin groups.
• Biochemical parameters (urea, creatinine, MDA, GSH) and kidney histopathology were assessed over seven days.
• Semiquantitative scores (SQS) were used to evaluate kidney damage.

Main Results:

• Magnesium sulfate administration significantly reduced urea and creatinine levels compared to colistin alone.
• Plasma malondialdehyde (MDA) levels were significantly lower in the magnesium sulfate + colistin group.
• Histopathological examination revealed reduced renal tubular grade, affected area, and SQS in rats treated with magnesium sulfate and colistin.

Conclusions:

• Magnesium sulfate demonstrates a nephroprotective effect against colistin-induced kidney injury in rats.
• This suggests magnesium sulfate could be a potential adjunct therapy to mitigate colistin nephrotoxicity.
• Further clinical studies are warranted to confirm these findings in human patients.